ETFA

Chr 15AR

electron transfer flavoprotein subunit alpha

Also known as: EMA, GA2, MADD

The ETFA protein forms part of the electron transfer flavoprotein complex that accepts electrons from multiple mitochondrial dehydrogenases and transfers them to the respiratory chain, playing an essential role in fatty acid oxidation and amino acid metabolism. Biallelic mutations cause glutaric acidemia type IIA, an autosomal recessive disorder affecting mitochondrial energy metabolism. The gene shows moderate constraint against loss-of-function variants (LOEUF 0.68), and affected individuals typically present with metabolic acidosis and distinctive organic acid profiles.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.681 OMIM phenotype
Clinical SummaryETFA
🧬
Gene-Disease Validity (ClinGen)
multiple acyl-CoA dehydrogenase deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
39 unique Pathogenic / Likely Pathogenic· 59 VUS of 200 total submissions
📖
GeneReview available — ETFA
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.68LOEUF
pLI 0.003
Z-score 2.66
OE 0.38 (0.220.68)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.06Z-score
OE missense 0.78 (0.680.89)
139 obs / 179.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.38 (0.220.68)
00.351.4
Missense OE0.78 (0.680.89)
00.61.4
Synonymous OE0.86
01.21.6
LoF obs/exp: 8 / 21.2Missense obs/exp: 139 / 179.0Syn Z: 0.89
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveETFA-related glutaric aciduriaLOFAR

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6744th %ile
GOF
0.5367th %ile
LOF
0.3551th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic10
Likely Pathogenic29
VUS59
Likely Benign96
Benign3
Conflicting3
10
Pathogenic
29
Likely Pathogenic
59
VUS
96
Likely Benign
3
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
5
0
5
0
10
Likely Pathogenic
26
2
1
0
29
VUS
0
49
10
0
59
Likely Benign
0
0
49
47
96
Benign
0
0
3
0
3
Conflicting
3
Total31516847200

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ETFA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →